股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: Guanze Medical Information Industry (Holding) Co., Ltd. | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02427 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 10,000,000,000 | HKD | | 0.01 | HKD | | 100,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 10,000,000,000 | HKD | | 0.01 | HKD | | 100, ...

Core Insights - LABUBU series from Pop Mart has seen explosive sales growth, with an 8-fold increase in the US and a 5-fold increase in Europe compared to last year, indicating a successful operational logic based on "familiar relationships" in the trendy toy sector [1] - Ark Health, recognized as the "first stock in AI chronic disease management," is applying a similar "familiar doctor-patient relationship" model in the online chronic disease management sector, establishing a new ecosystem for smart healthcare [1][2] - Citigroup has initiated coverage on Ark Health's brand, Ark Jianke, with a "buy" rating and a target price of HKD 8.5, suggesting over a 100% upside from the recent trading price of around HKD 4, based on the company's loyal and active user base [1] Company Performance - As of June 30, 2025, Ark Health's registered users reached 52.8 million, reflecting a steady year-on-year growth of 15.8%, while monthly active users surged by 34.4% to 11.9 million [3] - The number of registered doctors on the platform increased to 229,000, with 58.9% affiliated with top-tier hospitals, indicating a robust growth in both user and provider engagement [3] - The platform's user retention remains high, with a paid user repurchase rate rising to 85.4%, showcasing strong customer loyalty [3] Technological Integration - Ark Health has upgraded its "AI + H2H smart healthcare ecosystem," integrating advanced AI models to enhance operational efficiency and service quality [4] - The company has developed AI tools such as AI doctor assistants and AI customer service assistants, which have significantly improved the efficiency of healthcare providers and personalized health services [4] - Ark Health is positioned as a leader in the "AI + internet healthcare" space, leveraging technology to create a new benchmark in chronic disease management services [4] Market Outlook - The company aims to deepen the construction of its "AI + H2H smart healthcare ecosystem" and continue to cultivate the "familiar relationship" model, which is expected to drive ongoing technological and service upgrades [4] - With the potential in the trillion-dollar chronic disease management market, Ark Health is poised to make significant strides in the sector, providing differentiated practical examples for industry development [4]

（股份代號：2427） 變更香港主要營業地點的地址 Guanze Medical Information Industry (Holding) Co., Ltd.（「本公司」）董 事 會（「董 事 會」）謹此宣佈，自2025年9月1日起，本公司的香港主要營業地點將變更為香港 上環德輔道中199號無限極廣場29樓2908室。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容而產生或 因依賴該等內容而引致的任何損失承擔任何責任。 Guanze Medical Information Industry (Holding) Co., Ltd. （於開曼群島註冊成立的有限責任公司） 於本公告日期，執行董事為孟憲震先生及郭振宇先生，非執行董事為Meng Cathy女士，及獨 立非執行董事為趙斌博士、常世旺博士及黃文顯博士。 董事會主席 孟憲震 香港，2025年9月1日 本公司的電話及傳真號碼以及網址仍維持不變。 承董事會命 Guanze Medical Information Industry (Holding) C ...

Core Insights - GUANZE MEDICAL reported a total revenue of approximately RMB 31.855 million for the six months ending June 30, 2025, representing a year-on-year decrease of 20.42% primarily due to a decline in sales of medical imaging film products [1] - The gross profit for the period was RMB 13.383 million, down 38.83% compared to the previous year [1] - The company recorded a profit attributable to owners of RMB 3.368 million, contrasting with a loss of RMB 0.16 million in the same period last year, resulting in a basic earnings per share of RMB 0.003 [1] - The gross margin decreased by approximately 12.7 percentage points to about 42.0%, mainly due to a decline in the average selling price of medical imaging film products [1]

Core Viewpoint - GuanZe Medical (02427) reported a revenue of 31.855 million RMB for the six months ending June 30, 2025, representing a year-on-year decrease of 20.42% [1] - The company achieved a profit attributable to owners of 3.368 million RMB, marking a turnaround from a loss to profit [1] - Basic earnings per share were reported at 0.003 RMB [1] Financial Performance - Revenue for the period was 31.855 million RMB, down 20.42% compared to the previous year [1] - Profit attributable to owners was 3.368 million RMB, indicating a recovery from previous losses [1] - Basic earnings per share stood at 0.003 RMB [1]

智通财经APP讯，GUANZE MEDICAL(02427)发布截至2025年6月30日止6个月业绩，该集团期内取得收 入3185.5万元人民币，同比减少20.42%;公司拥有人应占溢利336.8万元，同比扭亏为盈;每股基本盈利 0.003元。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容而產生或 因依賴該等內容而引致的任何損失承擔任何責任。 Guanze Medical Information Industry (Holding) Co., Ltd. （於開曼群島註冊成立的有限責任公司） （股份代號：2427） 截至2025年6月30日止六個月 中期業績公告及 全球發售所得款項淨額用途變動 董事會欣然宣佈本集團截至2025年6月30日止六個月之未經審核簡明綜合中期 業績如下： 中期簡明綜合損益及其他全面收益表 截至2025年6月30日止六個月 | | | 截至6月30日止六個月 | | | --- | --- | --- | --- | | | | 2025年 | 2024年 | | | | （未經審核）（未經審核） | | | | 附註 | 人民幣千元 | 人民幣千元 | | 收入 | 5 | 31,855 | 40,030 | | 銷售成本 | | (18,472) | (18,150) | | 毛利 | | 13,383 | 21,8 ...

Group 1 - The company GUANZE MEDICAL (02427.HK) will hold a board meeting on August 27, 2025 [1] - The meeting will review and approve the interim results for the six months ending June 30, 2025, and discuss the proposal for an interim dividend, if any [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容而產生或 因依賴該等內容而引致的任何損失承擔任何責任。 Guanze Medical Information Industry (Holding) Co., Ltd. （於開曼群島註冊成立的有限責任公司） （股份代號：2427） 董事會會議通告 Guanze Medical Information Industry (Holding) Co., Ltd.（「本公司」）董 事 會（「董 事 會」）謹此宣佈，本公司謹訂於2025年8月27日（星期三）舉行董事會會議，藉以（其 中包括）(i)審議及酌情批准本公司及其附屬公司截至2025年6月30日止六個月之 未經審核中期業績；(ii)考慮宣派中期股息（如有）；及(iii)處理任何其他事項（如 有）。 承董事會命 Guanze Medical Information Industry (Holding) Co., Ltd. 董事會主席 孟憲震 香港，2025年8月13日 於本公告日期，董事會包括執行董事孟憲震先生及郭 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: Guanze Medical Information Industry (Holding) Co., Ltd. 呈交日期: 2025年8月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02427 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 10,000,000,000 | HKD | | 0.01 | HKD | | 100,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 10,000,000,000 ...